Cargando…

Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon

BACKGROUND: To foster access to care and reduce the burden of health expenditures on people living with HIV (PLHIV), several sub-Saharan African countries, including Cameroon, have adopted a policy of removing HIV-related fees, especially for antiretroviral treatment (ART). We investigate the impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Bousmah, Marwân-al-Qays, Nishimwe, Marie Libérée, Kuaban, Christopher, Boyer, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028721/
https://www.ncbi.nlm.nih.gov/pubmed/33827564
http://dx.doi.org/10.1186/s12913-021-06331-5
_version_ 1783675992711102464
author Bousmah, Marwân-al-Qays
Nishimwe, Marie Libérée
Kuaban, Christopher
Boyer, Sylvie
author_facet Bousmah, Marwân-al-Qays
Nishimwe, Marie Libérée
Kuaban, Christopher
Boyer, Sylvie
author_sort Bousmah, Marwân-al-Qays
collection PubMed
description BACKGROUND: To foster access to care and reduce the burden of health expenditures on people living with HIV (PLHIV), several sub-Saharan African countries, including Cameroon, have adopted a policy of removing HIV-related fees, especially for antiretroviral treatment (ART). We investigate the impact of Cameroon’s free antiretroviral treatment (ART) policy, enacted in May 2007, on catastrophic health expenditure (CHE) risk according to socioeconomic status, in PLHIV enrolled in the country’s treatment access program. METHODS: Based on primary data from two cross-sectional surveys of PLHIV outpatients in 2006–2007 and 2014 (i.e., before and after the policy’s implementation, respectively), we used inverse propensity score weighting to reduce covariate imbalances between participants in both surveys, combined with probit regressions of CHE incidence. The analysis included participants treated with ART in one of the 11 HIV services common to both surveys (n = 1275). RESULTS: The free ART policy was associated with a significantly lower risk of CHE only in the poorest PLHIV while no significant effect was found in lower-middle or upper socioeconomic status PLHIV. Unexpectedly, the risk of CHE was higher in those with middle socioeconomic status after the policy’s implementation. CONCLUSIONS: Our findings suggest that Cameroon’s free ART policy is pro-poor. As it only benefitted PLHIV with the lowest socioeconomic status, increased comprehensive HIV care coverage is needed to substantially reduce the risk of CHE and the associated risk of impoverishment for all PLHIV. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06331-5.
format Online
Article
Text
id pubmed-8028721
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80287212021-04-08 Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon Bousmah, Marwân-al-Qays Nishimwe, Marie Libérée Kuaban, Christopher Boyer, Sylvie BMC Health Serv Res Research Article BACKGROUND: To foster access to care and reduce the burden of health expenditures on people living with HIV (PLHIV), several sub-Saharan African countries, including Cameroon, have adopted a policy of removing HIV-related fees, especially for antiretroviral treatment (ART). We investigate the impact of Cameroon’s free antiretroviral treatment (ART) policy, enacted in May 2007, on catastrophic health expenditure (CHE) risk according to socioeconomic status, in PLHIV enrolled in the country’s treatment access program. METHODS: Based on primary data from two cross-sectional surveys of PLHIV outpatients in 2006–2007 and 2014 (i.e., before and after the policy’s implementation, respectively), we used inverse propensity score weighting to reduce covariate imbalances between participants in both surveys, combined with probit regressions of CHE incidence. The analysis included participants treated with ART in one of the 11 HIV services common to both surveys (n = 1275). RESULTS: The free ART policy was associated with a significantly lower risk of CHE only in the poorest PLHIV while no significant effect was found in lower-middle or upper socioeconomic status PLHIV. Unexpectedly, the risk of CHE was higher in those with middle socioeconomic status after the policy’s implementation. CONCLUSIONS: Our findings suggest that Cameroon’s free ART policy is pro-poor. As it only benefitted PLHIV with the lowest socioeconomic status, increased comprehensive HIV care coverage is needed to substantially reduce the risk of CHE and the associated risk of impoverishment for all PLHIV. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06331-5. BioMed Central 2021-04-07 /pmc/articles/PMC8028721/ /pubmed/33827564 http://dx.doi.org/10.1186/s12913-021-06331-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Bousmah, Marwân-al-Qays
Nishimwe, Marie Libérée
Kuaban, Christopher
Boyer, Sylvie
Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon
title Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon
title_full Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon
title_fullStr Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon
title_full_unstemmed Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon
title_short Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon
title_sort free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with hiv: evidence from cameroon
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028721/
https://www.ncbi.nlm.nih.gov/pubmed/33827564
http://dx.doi.org/10.1186/s12913-021-06331-5
work_keys_str_mv AT bousmahmarwanalqays freeaccesstoantiretroviraltreatmentandprotectionagainsttheriskofcatastrophichealthexpenditureinpeoplelivingwithhivevidencefromcameroon
AT nishimwemarieliberee freeaccesstoantiretroviraltreatmentandprotectionagainsttheriskofcatastrophichealthexpenditureinpeoplelivingwithhivevidencefromcameroon
AT kuabanchristopher freeaccesstoantiretroviraltreatmentandprotectionagainsttheriskofcatastrophichealthexpenditureinpeoplelivingwithhivevidencefromcameroon
AT boyersylvie freeaccesstoantiretroviraltreatmentandprotectionagainsttheriskofcatastrophichealthexpenditureinpeoplelivingwithhivevidencefromcameroon